mko2 personal page - To The Moon

mko2

mko2

No personal profile

26Follow

0Followers

1Topic

0Badge

2022-02-25

😮

The Excitement Is Over for GameStop Stock

2022-02-14

No matter what we will still have to be ready for the crash

4 Reasons Not to Worry About a Stock Market Crash

2022-02-03

This is the future

Biocardia Rises 30% on FDA Breakthrough Device Tag for Cardiamp System for Heart Failure

2022-01-24

Okay

Market Crash: 2 Stocks to Consider Buying

2022-01-21

Okay

KKR SPAC Is Said to Weigh Deal for PetSmart at $14 Billion Value

2022-01-04

👍

Tesla delivers 308,600 vehicles in Q4, beating estimates

2022-01-04

Tesla showing strength once again

Tesla delivers 308,600 vehicles in Q4, beating estimates

2021-09-04

Good

After criticism, Apple says it will delay child safety updates

2021-08-19

I doubt it. J&J vaccine safety record makes it far more wary to the public

Here's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna

2021-08-19

Like pls

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4088161478987360","uuid":"4088161478987360","gmtCreate":1625058524590,"gmtModify":1629103998842,"name":"mko2","pinyin":"mko2","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":26,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":20,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":1,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9030529014,"gmtCreate":1645758376921,"gmtModify":1676534061845,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"😮","listText":"😮","text":"😮","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030529014","repostId":"1145816604","repostType":4,"repost":{"id":"1145816604","kind":"news","pubTimestamp":1645751382,"share":"https://ttm.financial/m/news/1145816604?lang=&edition=fundamental","pubTime":"2022-02-25 09:09","market":"us","language":"en","title":"The Excitement Is Over for GameStop Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1145816604","media":"investorplace","summary":"We’re just over a year removed from the shocking short squeeze that upended Wall Street. In late Jan","content":"<html><head></head><body><p>We’re just over a year removed from the shocking short squeeze that upended Wall Street. In late January 2021, GameStop (NYSE:GME) stock surged from around $50 to nearly $500 in the span of a few days, opening investors’ minds to a whole new type of trade. If enough people started to buy a company’s stock , it seemed that the sky really was the limit for those shares.</p><p>However, the excitement about plays like GameStop and AMC (NYSE:AMC) has now fizzled. Predictions of subsequent short squeezes and trips to the moon have failed to materialize. In fact, as the stock market as a whole has corrected and speculative stocks have plunged,  names like AMC stock and GME stock have declined sharply as well. As it turns out, fundamentals actually do matter, and GameStop’s fundamentals are very poor.</p><h2>Where’s the Turnaround?</h2><p>For all the excitement about Ryan Cohen joining GameStop and trying to turn it around, the company has not made much progress.</p><p>The video-game industry had a record year in 2021, as the sector’s sales climbed 8%, exceeding $60 billion. GameStop, however, is generating large losses, and its revenue remains far short of its levels from a few years ago.</p><p>Analysts, on average, expect the company to report major losses in 2022, and their mean estimates call for its revenue growth to decelerate. Overall, for all the hype about GameStop, the company’s business appears to be struggling as much as ever.</p><h2>No Reason for Optimism</h2><p>Things aren’t likely to get much better for GameStop. For years, the company relied on secondhand game sales to drive crucial, high-margin revenue streams. However, this business is slowly becoming obsolete.</p><p>That’s largely due to streaming services that specialize in video games. Companies such as Microsoft (NASDAQ:MSFT) are launching successful streaming channels, making it less and less important to actually own games. Just as Netflix (NASDAQ:NFLX) eliminated the need for physical DVDs and Spotify (NYSE:SPOT) replaced CDs, gaming streaming services (along with digital download platforms like Steam) are likely to replace GameStop eventually.</p><p>Adding to that transition is the consolidation in the gaming industry. That is, in order to broaden their product offerings, companies are merging with each other. Microsoft’s  acquisition of Activision (NASDAQ:ATVI) will be particularly problematic for GameStop.</p><p>Activision has created many of the best-selling game series of all time. Now all of those games will be under Microsoft’s control and can quickly be added to the software giant’s streaming system, cutting out the middleman i.e. GameStop.</p><h2>No Monopoly on NFTs</h2><p>A big focus for GameStop recently has been cryptocurrency and non-fungible tokens (NFTs). But that initiative is unlikely to be very successful. A group of investors backed by the controversial internet marketer, Tai Lopez, bought Radio Shack’s intellectual property and are hoping to create a cryptocurrency and NFT ecosystem with the IP. While they’re at it, why not turn Kodak and Blockbuster into crypto plays as well? Kodak, after all, had its short-lived KodakCoin project.</p><p>My point is that there are many other companies which will be able to easily compete with GameStop in the cryptocurrency space. It’s not hard to grab some IP that appeals to millennials and use it to launch a cryptocurrency or NFT project. A much harder challenge. however, is making such a project impactful on society or financial markets.</p><p>GameStop was one of the first “old economy” companies to embrace cryptocurrency as a marketing tool. But many firms have followed in its footsteps, and GameStop’s potential first-mover advantage in the space has faded.</p><h2>The Verdict on GME Stock</h2><p>GameStop became a fascinating story in January 2021. It pitted a bunch of renegade traders against some hedge funds and market makers in a compelling clash. The first season of GameStop versus Wall Street was very dramatic.</p><p>But like a TV series that has gone on for way too many years, GME stock is no longer such a compelling story. Meme stocks have plunged, and the shares of brokerage firms such as Robinhood (NASDAQ:HOOD) have collapsed as their trading activity and profits have dried up.</p><p>And, most importantly, the possibility of a short squeeze ended months ago for GameStop. By now, anyone shorting GME stock who was going to cover their positions already did so ages ago.</p><p>GameStop at this point is a struggling video game retailer. It has some cash, which gives it a fighting chance to launch a new business model.</p><p>So far, however, its efforts in crypto and NFTs have been profoundly underwhelming. And the e-commerce sector is losing steam in general; the shares of Ryan Cohen’s original company, Chewy (NYSE:CHWY) have crashed. If GameStop was supposed to be the Chewy of video games, that’s not such an appealing goal now.</p><p>GameStop had a sensational run, but it’s over,  and it’s time to move on.</p></body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Excitement Is Over for GameStop Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Excitement Is Over for GameStop Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-25 09:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/02/the-excitement-is-over-for-gamestop-stock/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We’re just over a year removed from the shocking short squeeze that upended Wall Street. In late January 2021, GameStop (NYSE:GME) stock surged from around $50 to nearly $500 in the span of a few days...</p>\n\n<a href=\"https://investorplace.com/2022/02/the-excitement-is-over-for-gamestop-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://investorplace.com/2022/02/the-excitement-is-over-for-gamestop-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145816604","content_text":"We’re just over a year removed from the shocking short squeeze that upended Wall Street. In late January 2021, GameStop (NYSE:GME) stock surged from around $50 to nearly $500 in the span of a few days, opening investors’ minds to a whole new type of trade. If enough people started to buy a company’s stock , it seemed that the sky really was the limit for those shares.However, the excitement about plays like GameStop and AMC (NYSE:AMC) has now fizzled. Predictions of subsequent short squeezes and trips to the moon have failed to materialize. In fact, as the stock market as a whole has corrected and speculative stocks have plunged,  names like AMC stock and GME stock have declined sharply as well. As it turns out, fundamentals actually do matter, and GameStop’s fundamentals are very poor.Where’s the Turnaround?For all the excitement about Ryan Cohen joining GameStop and trying to turn it around, the company has not made much progress.The video-game industry had a record year in 2021, as the sector’s sales climbed 8%, exceeding $60 billion. GameStop, however, is generating large losses, and its revenue remains far short of its levels from a few years ago.Analysts, on average, expect the company to report major losses in 2022, and their mean estimates call for its revenue growth to decelerate. Overall, for all the hype about GameStop, the company’s business appears to be struggling as much as ever.No Reason for OptimismThings aren’t likely to get much better for GameStop. For years, the company relied on secondhand game sales to drive crucial, high-margin revenue streams. However, this business is slowly becoming obsolete.That’s largely due to streaming services that specialize in video games. Companies such as Microsoft (NASDAQ:MSFT) are launching successful streaming channels, making it less and less important to actually own games. Just as Netflix (NASDAQ:NFLX) eliminated the need for physical DVDs and Spotify (NYSE:SPOT) replaced CDs, gaming streaming services (along with digital download platforms like Steam) are likely to replace GameStop eventually.Adding to that transition is the consolidation in the gaming industry. That is, in order to broaden their product offerings, companies are merging with each other. Microsoft’s  acquisition of Activision (NASDAQ:ATVI) will be particularly problematic for GameStop.Activision has created many of the best-selling game series of all time. Now all of those games will be under Microsoft’s control and can quickly be added to the software giant’s streaming system, cutting out the middleman i.e. GameStop.No Monopoly on NFTsA big focus for GameStop recently has been cryptocurrency and non-fungible tokens (NFTs). But that initiative is unlikely to be very successful. A group of investors backed by the controversial internet marketer, Tai Lopez, bought Radio Shack’s intellectual property and are hoping to create a cryptocurrency and NFT ecosystem with the IP. While they’re at it, why not turn Kodak and Blockbuster into crypto plays as well? Kodak, after all, had its short-lived KodakCoin project.My point is that there are many other companies which will be able to easily compete with GameStop in the cryptocurrency space. It’s not hard to grab some IP that appeals to millennials and use it to launch a cryptocurrency or NFT project. A much harder challenge. however, is making such a project impactful on society or financial markets.GameStop was one of the first “old economy” companies to embrace cryptocurrency as a marketing tool. But many firms have followed in its footsteps, and GameStop’s potential first-mover advantage in the space has faded.The Verdict on GME StockGameStop became a fascinating story in January 2021. It pitted a bunch of renegade traders against some hedge funds and market makers in a compelling clash. The first season of GameStop versus Wall Street was very dramatic.But like a TV series that has gone on for way too many years, GME stock is no longer such a compelling story. Meme stocks have plunged, and the shares of brokerage firms such as Robinhood (NASDAQ:HOOD) have collapsed as their trading activity and profits have dried up.And, most importantly, the possibility of a short squeeze ended months ago for GameStop. By now, anyone shorting GME stock who was going to cover their positions already did so ages ago.GameStop at this point is a struggling video game retailer. It has some cash, which gives it a fighting chance to launch a new business model.So far, however, its efforts in crypto and NFTs have been profoundly underwhelming. And the e-commerce sector is losing steam in general; the shares of Ryan Cohen’s original company, Chewy (NYSE:CHWY) have crashed. If GameStop was supposed to be the Chewy of video games, that’s not such an appealing goal now.GameStop had a sensational run, but it’s over,  and it’s time to move on.","news_type":1},"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9095130167,"gmtCreate":1644848444599,"gmtModify":1676533967448,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"No matter what we will still have to be ready for the crash","listText":"No matter what we will still have to be ready for the crash","text":"No matter what we will still have to be ready for the crash","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095130167","repostId":"2211652081","repostType":4,"repost":{"id":"2211652081","kind":"highlight","pubTimestamp":1644847200,"share":"https://ttm.financial/m/news/2211652081?lang=&edition=fundamental","pubTime":"2022-02-14 22:00","market":"us","language":"en","title":"4 Reasons Not to Worry About a Stock Market Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2211652081","media":"Motley Fool","summary":"Market crashes happen. You can't prevent them, but you can put yourself in a position to emerge stronger once they pass.","content":"<html><head></head><body><p>The stock market will crash again. It&#39;s not a question of whether, but rather when. Perhaps the biggest near-term risk is that high and still rising inflation might provide the push that causes the next major drop. How? Well, the Federal Reserve&#39;s expedited meeting scheduled for Monday might lead to faster and more aggressive tapering than the market already expects. That could cause a shift out of riskier assets like stocks, leading to a market correction.</p><p>Whether or not that particular scenario comes into play, the reality is that stocks can go down as well as up. If you recognize that and plan for it appropriately, you can make it through a mere market crash -- and emerge on the other side in a great spot to ride any subsequent recovery.</p><p>With that in mind, here are four reasons not to worry about a stock-market crash.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1237784dd4415f4c114f5922023f8e01\" tg-width=\"700\" tg-height=\"312\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>1. You don&#39;t need to sell your stocks today</h2><p>As a general rule, you should not have money invested in stocks that you expect you&#39;ll need to spend within the next five years. If you have followed that guideline, it becomes much easier to stomach a market crash. It&#39;s still not fun, but you can make it through.</p><p>After all, if you don&#39;t need the money immediately, then you don&#39;t have to sell shares when they&#39;re low just to cover your bills. That gives you the chance to not only hold on through a crash, but also to potentially add more to strong companies while they&#39;re near their cheapest. The ability to buy low -- instead of selling low -- allows you to end up in a better spot once the crash passes.</p><h2>2. You have emergency money stocked away, just in case</h2><p>One of the bigger risks most people face when the market crashes isn&#39;t the crash itself, but rather the fact that a down market is often linked to job losses. Even if you fully intend to hold on to your stocks through a crash, if you find yourself without a paycheck and with no cash buffer, you could wind up needing to sell due to that job loss.</p><p>A three- to six-month emergency fund buys you time to both look for another job and figure out ways to cut costs before you feel forced to sell your shares. It&#39;s a buffer that can come in incredibly handy in a tough environment. It&#39;s also <a href=\"https://laohu8.com/S/AONE.U\">one</a> of those things that you hope you&#39;ll never have to use -- but if you do, you&#39;ll be incredibly glad it&#39;s there when you need it.</p><h2>3. You own strong companies that still pay their dividends</h2><p>The beauty of a stock&#39;s dividend is that it tends to get paid based on the underlying company&#39;s ability to generate cash, rather than on the stock market&#39;s short-term mood. When companies continue to pay their dividends in a down market, that helps investors in a number of ways.</p><p>First, the cash itself can be used to buy more shares while they&#39;re down -- either of the company that paid the dividend, or of a different one that looks like a compelling value at a low price. That cash becomes available without you having to sell stock or somehow scaring up money from another source, which can be comforting if you&#39;re a bit nervous about the future.</p><p>Second, the fact that companies continue to make their payments from available cash flows can provide a calming effect for investors, even as the market appears to panic around them. After all, there&#39;s nothing quite like cold, hard cash to remind people that there&#39;s a business behind each stock. If a dividend is still supported and getting paid, it means there&#39;s still a successful company there, no matter what the stock price might say at the moment.</p><h2>4. You have a value investor&#39;s mindset</h2><p>Ultimately, a share of stock is an ownership stake in a business. If that business is currently profitable and expected to remain that way, each share is certainly worth <i>something</i>. Value investors recognize that a company&#39;s intrinsic worth is based on its ability to generate cash over time, and not simply on what the market thinks its shares should be priced at today.</p><p>As a result, a market crash can make great companies&#39; shares available at a price below what those value investors believe they&#39;re really worth. That sort of pricing turns value investors into aggressive buyers during a crash, and it&#39;s a key part of the strategy that helped Warren Buffett earn and expand his fortune.</p><p>Especially when combined with the first three reasons not to worry about a stock-market crash, this fourth reason can actually give you an opportunity to profit from one. After all, if you&#39;ve got the cash to ride out the decline <i>and</i> the wherewithal to buy near the lows, you have the opportunity to make some serious coin in any subsequent recovery.</p><h2>Are you ready for the next crash?</h2><p>While these four factors can help you make it through a market crash with much less worry, they all work much better if you have them in place before you need them. So start getting your plan in place today. That way, you&#39;ll be in a much better place the next time the market crashes.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Reasons Not to Worry About a Stock Market Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Reasons Not to Worry About a Stock Market Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-14 22:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/13/4-reasons-not-to-worry-about-a-stock-market-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market will crash again. It's not a question of whether, but rather when. Perhaps the biggest near-term risk is that high and still rising inflation might provide the push that causes the ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/13/4-reasons-not-to-worry-about-a-stock-market-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.fool.com/investing/2022/02/13/4-reasons-not-to-worry-about-a-stock-market-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211652081","content_text":"The stock market will crash again. It's not a question of whether, but rather when. Perhaps the biggest near-term risk is that high and still rising inflation might provide the push that causes the next major drop. How? Well, the Federal Reserve's expedited meeting scheduled for Monday might lead to faster and more aggressive tapering than the market already expects. That could cause a shift out of riskier assets like stocks, leading to a market correction.Whether or not that particular scenario comes into play, the reality is that stocks can go down as well as up. If you recognize that and plan for it appropriately, you can make it through a mere market crash -- and emerge on the other side in a great spot to ride any subsequent recovery.With that in mind, here are four reasons not to worry about a stock-market crash.Image source: Getty Images.1. You don't need to sell your stocks todayAs a general rule, you should not have money invested in stocks that you expect you'll need to spend within the next five years. If you have followed that guideline, it becomes much easier to stomach a market crash. It's still not fun, but you can make it through.After all, if you don't need the money immediately, then you don't have to sell shares when they're low just to cover your bills. That gives you the chance to not only hold on through a crash, but also to potentially add more to strong companies while they're near their cheapest. The ability to buy low -- instead of selling low -- allows you to end up in a better spot once the crash passes.2. You have emergency money stocked away, just in caseOne of the bigger risks most people face when the market crashes isn't the crash itself, but rather the fact that a down market is often linked to job losses. Even if you fully intend to hold on to your stocks through a crash, if you find yourself without a paycheck and with no cash buffer, you could wind up needing to sell due to that job loss.A three- to six-month emergency fund buys you time to both look for another job and figure out ways to cut costs before you feel forced to sell your shares. It's a buffer that can come in incredibly handy in a tough environment. It's also one of those things that you hope you'll never have to use -- but if you do, you'll be incredibly glad it's there when you need it.3. You own strong companies that still pay their dividendsThe beauty of a stock's dividend is that it tends to get paid based on the underlying company's ability to generate cash, rather than on the stock market's short-term mood. When companies continue to pay their dividends in a down market, that helps investors in a number of ways.First, the cash itself can be used to buy more shares while they're down -- either of the company that paid the dividend, or of a different one that looks like a compelling value at a low price. That cash becomes available without you having to sell stock or somehow scaring up money from another source, which can be comforting if you're a bit nervous about the future.Second, the fact that companies continue to make their payments from available cash flows can provide a calming effect for investors, even as the market appears to panic around them. After all, there's nothing quite like cold, hard cash to remind people that there's a business behind each stock. If a dividend is still supported and getting paid, it means there's still a successful company there, no matter what the stock price might say at the moment.4. You have a value investor's mindsetUltimately, a share of stock is an ownership stake in a business. If that business is currently profitable and expected to remain that way, each share is certainly worth something. Value investors recognize that a company's intrinsic worth is based on its ability to generate cash over time, and not simply on what the market thinks its shares should be priced at today.As a result, a market crash can make great companies' shares available at a price below what those value investors believe they're really worth. That sort of pricing turns value investors into aggressive buyers during a crash, and it's a key part of the strategy that helped Warren Buffett earn and expand his fortune.Especially when combined with the first three reasons not to worry about a stock-market crash, this fourth reason can actually give you an opportunity to profit from one. After all, if you've got the cash to ride out the decline and the wherewithal to buy near the lows, you have the opportunity to make some serious coin in any subsequent recovery.Are you ready for the next crash?While these four factors can help you make it through a market crash with much less worry, they all work much better if you have them in place before you need them. So start getting your plan in place today. That way, you'll be in a much better place the next time the market crashes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":370,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"content":"market correction is inevitable","text":"market correction is inevitable","html":"market correction is inevitable"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091513403,"gmtCreate":1643898349602,"gmtModify":1676533868988,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"This is the future","listText":"This is the future","text":"This is the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091513403","repostId":"1196144953","repostType":4,"repost":{"id":"1196144953","kind":"news","pubTimestamp":1643896451,"share":"https://ttm.financial/m/news/1196144953?lang=&edition=fundamental","pubTime":"2022-02-03 21:54","market":"us","language":"en","title":"Biocardia Rises 30% on FDA Breakthrough Device Tag for Cardiamp System for Heart Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=1196144953","media":"Seeking Alpha","summary":"The U.S. Food and Drug Administration (FDA)granted breakthrough device designation to BioCardia's(NA","content":"<html><head></head><body><ul><li>The U.S. Food and Drug Administration (FDA)granted breakthrough device designation to BioCardia&#39;s(NASDAQ:BCDA)CardiAMP Cell Therapy System to treat heart failure.</li><li>The company said it is believed to be the first cardiac cell therapy to receive the FDA&#39;s breakthrough device status.</li><li>The CardiAMP Cell Therapy Heart Failure Trial in the U.S. is currently enrolling patients to evaluate the effectiveness of the system in improving survival, reducing major adverse cardiac events, enhancing functional capacity, and improving quality of life for patients.</li><li>The company said the system has shown no incidence of mortality at one year in its phase 2 trial or in the 10-patient roll-in cohort from the phase 3 trial that is currently enrolling.</li><li>CardiAMP Cell Therapy uses a patient’s own (autologous) bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure.</li><li>BCDA +29.94% premarket to $2.04</li></ul></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biocardia Rises 30% on FDA Breakthrough Device Tag for Cardiamp System for Heart Failure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiocardia Rises 30% on FDA Breakthrough Device Tag for Cardiamp System for Heart Failure\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-03 21:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3795517-biocardia-rises-30-on-fda-breakthrough-device-tag-for-cardiamp-system-for-heart-failure><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The U.S. Food and Drug Administration (FDA)granted breakthrough device designation to BioCardia's(NASDAQ:BCDA)CardiAMP Cell Therapy System to treat heart failure.The company said it is believed to be ...</p>\n\n<a href=\"https://seekingalpha.com/news/3795517-biocardia-rises-30-on-fda-breakthrough-device-tag-for-cardiamp-system-for-heart-failure\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCDA":"BioCardia"},"source_url":"https://seekingalpha.com/news/3795517-biocardia-rises-30-on-fda-breakthrough-device-tag-for-cardiamp-system-for-heart-failure","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196144953","content_text":"The U.S. Food and Drug Administration (FDA)granted breakthrough device designation to BioCardia's(NASDAQ:BCDA)CardiAMP Cell Therapy System to treat heart failure.The company said it is believed to be the first cardiac cell therapy to receive the FDA's breakthrough device status.The CardiAMP Cell Therapy Heart Failure Trial in the U.S. is currently enrolling patients to evaluate the effectiveness of the system in improving survival, reducing major adverse cardiac events, enhancing functional capacity, and improving quality of life for patients.The company said the system has shown no incidence of mortality at one year in its phase 2 trial or in the 10-patient roll-in cohort from the phase 3 trial that is currently enrolling.CardiAMP Cell Therapy uses a patient’s own (autologous) bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure.BCDA +29.94% premarket to $2.04","news_type":1},"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007758629,"gmtCreate":1643019750308,"gmtModify":1676533765328,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007758629","repostId":"2205020146","repostType":4,"repost":{"id":"2205020146","kind":"highlight","pubTimestamp":1643005286,"share":"https://ttm.financial/m/news/2205020146?lang=&edition=fundamental","pubTime":"2022-01-24 14:21","market":"us","language":"en","title":"Market Crash: 2 Stocks to Consider Buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2205020146","media":"Motley Fool","summary":"Two of the biggest companies in the world may be two of the market's best opportunities.","content":"<html><head></head><body><p>Though a 7.5% sell-off of the <b>S&amp;P 500</b> year to date may not exactly sound like a market crash, there are certainly some parts of the market that have been hit particularly hard recently. Namely, many growth stocks have been crushed. <b>Netflix</b>, <b>Roku</b>, and <b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications</b> are all good examples of tocks that have taken especially big hits. The three stocks have slid 35%, 33%, and 19%, year to date, respectively.</p><p>Of course, these are not the times to be net sellers of stocks. On the contrary, when things go on sale investors should be on the lookout for buying opportunities. As famed investor Warren Buffett has said, &#34;Be fearful when others are greedy and greedy when others are fearful.&#34;</p><p>Here are two stocks that are beginning to look especially attractive.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d1a80e2bc655d91abe37c8c8083b1ab\" tg-width=\"700\" tg-height=\"510\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>Amazon</h2><p>Shares of <b>Amazon</b> (NASDAQ:AMZN) have slid 14% year to date. Though the company&#39;s decelerating revenue growth may concern some investors, there&#39;s a good explanation for it. The company has been up against some incredibly tough year-ago comparisons. Furthermore, there was undoubtedly some pent-up demand for e-commerce offerings when global COVID-19 lockdowns were more prevalent. Some cooling off is totally normal.</p><p>The stock&#39;s price-to-earnings ratio of 56 may seem expensive. But here&#39;s what investors should keep in mind. Earnings are likely to grow rapidly in the coming years because Amazon is poised to benefit from margin expansion, as it has over the last few years. The company&#39;s business model has proven to have significant operating leverage thanks to economies of scale. To this end, the consensus analyst forecast currently calls for Amazon&#39;s earnings per share to grow at an average annualized rate of 36% over the next five years. Growth like this would easily justify the stock&#39;s current valuation.</p><h2>Apple</h2><p><b>Apple</b>&#39;s (NASDAQ:AAPL) shares have fallen 8% year to date, giving investors a great opportunity to buy <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest-quality tech companies in the world. Even in the face of supply shortages in the company&#39;s most recently reported quarter, revenue grew 29% year over year during the period.</p><p>&#34;Our record September quarter results capped off a remarkable fiscal year of strong double-digit growth, during which we set new revenue records in all of our geographic segments and product categories in spite of continued uncertainty in the macro environment,&#34; said Apple CFO Luca Maestri in the company&#39;s fiscal fourth-quarter earnings release. &#34;The combination of our record sales performance, unmatched customer loyalty, and strength of our ecosystem drove our active installed base of devices to a new all-time high.&#34;</p><p>On top of all of this, the company was able to return $24 billion to shareholders during the 3-month period. About $4 billion of this sum was dividends. The other $20 billion was represented in share repurchases.</p><p>If you have a hard time justifying Apple&#39;s $2.7 trillion market capitalization, take a look at the company&#39;s cash flow statement. Apple raked in about $93 billion in free cash flow in fiscal 2021 alone.</p><p>Sure, Apple&#39;s growth will likely slow from its current blistering pace. But its conservative valuation today seems to already price in this deceleration.</p><p>Investors will get updates on both companies&#39; recent financial performance soon. Apple reports results for its first quarter of fiscal 2022 on Thursday, Jan. 27. Amazon&#39;s fourth-quarter earnings report is on Thursday, Feb. 3.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Crash: 2 Stocks to Consider Buying</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Crash: 2 Stocks to Consider Buying\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-24 14:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/23/market-crash-2-stocks-to-consider-buying/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Though a 7.5% sell-off of the S&P 500 year to date may not exactly sound like a market crash, there are certainly some parts of the market that have been hit particularly hard recently. Namely, many ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/23/market-crash-2-stocks-to-consider-buying/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4507":"流媒体概念","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4527":"明星科技股","BK4501":"段永平概念","BK4538":"云计算","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4505":"高瓴资本持仓","BK4561":"索罗斯持仓","BK4548":"巴美列捷福持仓","BK4170":"电脑硬件、储存设备及电脑周边","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓"},"source_url":"https://www.fool.com/investing/2022/01/23/market-crash-2-stocks-to-consider-buying/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205020146","content_text":"Though a 7.5% sell-off of the S&P 500 year to date may not exactly sound like a market crash, there are certainly some parts of the market that have been hit particularly hard recently. Namely, many growth stocks have been crushed. Netflix, Roku, and Zoom Video Communications are all good examples of tocks that have taken especially big hits. The three stocks have slid 35%, 33%, and 19%, year to date, respectively.Of course, these are not the times to be net sellers of stocks. On the contrary, when things go on sale investors should be on the lookout for buying opportunities. As famed investor Warren Buffett has said, \"Be fearful when others are greedy and greedy when others are fearful.\"Here are two stocks that are beginning to look especially attractive.Image source: Getty Images.AmazonShares of Amazon (NASDAQ:AMZN) have slid 14% year to date. Though the company's decelerating revenue growth may concern some investors, there's a good explanation for it. The company has been up against some incredibly tough year-ago comparisons. Furthermore, there was undoubtedly some pent-up demand for e-commerce offerings when global COVID-19 lockdowns were more prevalent. Some cooling off is totally normal.The stock's price-to-earnings ratio of 56 may seem expensive. But here's what investors should keep in mind. Earnings are likely to grow rapidly in the coming years because Amazon is poised to benefit from margin expansion, as it has over the last few years. The company's business model has proven to have significant operating leverage thanks to economies of scale. To this end, the consensus analyst forecast currently calls for Amazon's earnings per share to grow at an average annualized rate of 36% over the next five years. Growth like this would easily justify the stock's current valuation.AppleApple's (NASDAQ:AAPL) shares have fallen 8% year to date, giving investors a great opportunity to buy one of the highest-quality tech companies in the world. Even in the face of supply shortages in the company's most recently reported quarter, revenue grew 29% year over year during the period.\"Our record September quarter results capped off a remarkable fiscal year of strong double-digit growth, during which we set new revenue records in all of our geographic segments and product categories in spite of continued uncertainty in the macro environment,\" said Apple CFO Luca Maestri in the company's fiscal fourth-quarter earnings release. \"The combination of our record sales performance, unmatched customer loyalty, and strength of our ecosystem drove our active installed base of devices to a new all-time high.\"On top of all of this, the company was able to return $24 billion to shareholders during the 3-month period. About $4 billion of this sum was dividends. The other $20 billion was represented in share repurchases.If you have a hard time justifying Apple's $2.7 trillion market capitalization, take a look at the company's cash flow statement. Apple raked in about $93 billion in free cash flow in fiscal 2021 alone.Sure, Apple's growth will likely slow from its current blistering pace. But its conservative valuation today seems to already price in this deceleration.Investors will get updates on both companies' recent financial performance soon. Apple reports results for its first quarter of fiscal 2022 on Thursday, Jan. 27. Amazon's fourth-quarter earnings report is on Thursday, Feb. 3.","news_type":1},"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007951064,"gmtCreate":1642748141098,"gmtModify":1676533742677,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007951064","repostId":"1149128826","repostType":4,"repost":{"id":"1149128826","kind":"news","pubTimestamp":1642736648,"share":"https://ttm.financial/m/news/1149128826?lang=&edition=fundamental","pubTime":"2022-01-21 11:44","market":"us","language":"en","title":"KKR SPAC Is Said to Weigh Deal for PetSmart at $14 Billion Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1149128826","media":"Bloomberg","summary":"PetSmart is in talks to go public through a blank-check company backed by private equity firm KKR & ","content":"<html><head></head><body><p>PetSmart is in talks to go public through a blank-check company backed by private equity firm KKR &amp; Co., according to people familiar with the matter.</p><p>The pet supply retailer, backed by BC Partners, would be valued in the transaction at $14 billion including debt, said one of the people, who asked not to be identified because the information was private.</p><p>KKR Acquisition Holdings I Corp., the special purpose acquisition company, raised $1.38 billion in its initial public offering last March. As with other SPAC deals, PetSmart would become a publicly trading company after merging with KKR Acquisition, the people said.</p><p>The discussions are in early stages, the people said, adding that the talks could still end without an agreement.</p><p>Representatives for PetSmart and BC Partners didn’t immediately respond to requests for comment. A spokesperson for KKR declined to comment.</p><p>Private equity firms led by BC Partners bought the chain in 2015 in an $8.7 billion deal, and later added debt to PetSmart when it acquired online pet store Chewy.</p><p>Despite a rocky period that saw the buyout debt fall to distressed levels, the companies’ fortunes rebounded amid growing spending on pets and pet care. BC Partners later split PetSmart’s operations from Chewy’s and sold shares after the online retailer went public.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KKR SPAC Is Said to Weigh Deal for PetSmart at $14 Billion Value</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKKR SPAC Is Said to Weigh Deal for PetSmart at $14 Billion Value\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-21 11:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-01-21/kkr-spac-is-said-to-weigh-deal-for-petsmart-at-14-billion-value><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PetSmart is in talks to go public through a blank-check company backed by private equity firm KKR & Co., according to people familiar with the matter.The pet supply retailer, backed by BC Partners, ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-21/kkr-spac-is-said-to-weigh-deal-for-petsmart-at-14-billion-value\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/news/articles/2022-01-21/kkr-spac-is-said-to-weigh-deal-for-petsmart-at-14-billion-value","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149128826","content_text":"PetSmart is in talks to go public through a blank-check company backed by private equity firm KKR & Co., according to people familiar with the matter.The pet supply retailer, backed by BC Partners, would be valued in the transaction at $14 billion including debt, said one of the people, who asked not to be identified because the information was private.KKR Acquisition Holdings I Corp., the special purpose acquisition company, raised $1.38 billion in its initial public offering last March. As with other SPAC deals, PetSmart would become a publicly trading company after merging with KKR Acquisition, the people said.The discussions are in early stages, the people said, adding that the talks could still end without an agreement.Representatives for PetSmart and BC Partners didn’t immediately respond to requests for comment. A spokesperson for KKR declined to comment.Private equity firms led by BC Partners bought the chain in 2015 in an $8.7 billion deal, and later added debt to PetSmart when it acquired online pet store Chewy.Despite a rocky period that saw the buyout debt fall to distressed levels, the companies’ fortunes rebounded amid growing spending on pets and pet care. BC Partners later split PetSmart’s operations from Chewy’s and sold shares after the online retailer went public.","news_type":1},"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001698313,"gmtCreate":1641228211260,"gmtModify":1676533585630,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001698313","repostId":"2200544080","repostType":2,"repost":{"id":"2200544080","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641163106,"share":"https://ttm.financial/m/news/2200544080?lang=&edition=fundamental","pubTime":"2022-01-03 06:38","market":"us","language":"en","title":"Tesla delivers 308,600 vehicles in Q4, beating estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2200544080","media":"Reuters","summary":"Jan 2  - Tesla Incon Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and ","content":"<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla delivers 308,600 vehicles in Q4, beating estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla delivers 308,600 vehicles in Q4, beating estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-03 06:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4099":"汽车制造商","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4555":"新能源车","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200544080","content_text":"Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.\"Great work by Tesla team worldwide!\" Musk wrote on Twitter.His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.Tesla ships China-made models to Europe and some Asian countries.On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for \"quite a while.\"NEW FACTORIES\"They have beaten all the odds,\" Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.\"The first is the demand for their products is through the roof. And the second is they're doing a great job of meeting that demand,\" he said.Munster said he expected Tesla's deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.'SUPER CRAZY' SHORTAGESIn 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.Musk, who previously said, \"2021 has been the year of super crazy supply chain shortages,\" said in October that he was optimistic that those issues would pass in 2022.The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company's shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.Overall, Tesla shares gained 50% last year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001698011,"gmtCreate":1641228150205,"gmtModify":1676533585638,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Tesla showing strength once again","listText":"Tesla showing strength once again","text":"Tesla showing strength once again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001698011","repostId":"2200544080","repostType":2,"repost":{"id":"2200544080","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641163106,"share":"https://ttm.financial/m/news/2200544080?lang=&edition=fundamental","pubTime":"2022-01-03 06:38","market":"us","language":"en","title":"Tesla delivers 308,600 vehicles in Q4, beating estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2200544080","media":"Reuters","summary":"Jan 2  - Tesla Incon Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and ","content":"<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla delivers 308,600 vehicles in Q4, beating estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla delivers 308,600 vehicles in Q4, beating estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-03 06:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4099":"汽车制造商","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4555":"新能源车","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200544080","content_text":"Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.\"Great work by Tesla team worldwide!\" Musk wrote on Twitter.His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.Tesla ships China-made models to Europe and some Asian countries.On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for \"quite a while.\"NEW FACTORIES\"They have beaten all the odds,\" Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.\"The first is the demand for their products is through the roof. And the second is they're doing a great job of meeting that demand,\" he said.Munster said he expected Tesla's deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.'SUPER CRAZY' SHORTAGESIn 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.Musk, who previously said, \"2021 has been the year of super crazy supply chain shortages,\" said in October that he was optimistic that those issues would pass in 2022.The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company's shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.Overall, Tesla shares gained 50% last year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814311016,"gmtCreate":1630762091735,"gmtModify":1676530391497,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/814311016","repostId":"1107645720","repostType":4,"repost":{"id":"1107645720","kind":"news","pubTimestamp":1630679339,"share":"https://ttm.financial/m/news/1107645720?lang=&edition=fundamental","pubTime":"2021-09-03 22:28","market":"us","language":"en","title":"After criticism, Apple says it will delay child safety updates","url":"https://stock-news.laohu8.com/highlight/detail?id=1107645720","media":"Reuters","summary":"Sept 3 (Reuters) - Apple Inc said on Friday it would take more time to collect feedback and improve ","content":"<p>Sept 3 (Reuters) - Apple Inc said on Friday it would take more time to collect feedback and improve proposed child safety features after the criticism of the system on privacy and other grounds both inside and outside the company.</p>\n<p>Apple's promise last month to check U.S. customer phones and computers for child sex abuse images sparked a global backlash from a wide range of rights groups, with employees also criticizing the plan internally.</p>\n<p>Critics argued the feature could be exploited by repressive governments looking to find other material for censorship or arrests and would also be impossible for outside researchers to determine whether Apple was only checking a small set of on-device content.</p>\n<p>Apple countered that it would allow security researchers to verify its claims, but the company on Friday said it would take more time to make changes to the system.</p>\n<p>\"Based on feedback from customers, advocacy groups, researchers and others, we have decided to take additional time over the coming months to collect input and make improvements before releasing these critically important child safety features,\" the company said in a statement on Friday.</p>\n<p>Matthew Green, a cybersecurity researcher at Johns Hopkins University who had criticized Apple's move, said the Apple's move was \"promising.\"</p>\n<p>Green said on Twitter that Apple should \"be clear about why you’re scanning and what you’re scanning. Going from scanning nothing (but email attachments) to scanning everyone’s private photo library was an enormous delta. You need to justify escalations like this.\"</p>\n<p>Apple had been playing defense on the plan for weeks, and had already offered a series of explanations and documents to show that the risks of false detections were low.</p>\n<p>It had planned to roll out the feature for iPhones, iPads, and Mac with software updates later this year in the United States.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After criticism, Apple says it will delay child safety updates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter criticism, Apple says it will delay child safety updates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 22:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/2-apple-says-delays-child-132336835.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sept 3 (Reuters) - Apple Inc said on Friday it would take more time to collect feedback and improve proposed child safety features after the criticism of the system on privacy and other grounds both ...</p>\n\n<a href=\"https://finance.yahoo.com/news/2-apple-says-delays-child-132336835.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://finance.yahoo.com/news/2-apple-says-delays-child-132336835.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107645720","content_text":"Sept 3 (Reuters) - Apple Inc said on Friday it would take more time to collect feedback and improve proposed child safety features after the criticism of the system on privacy and other grounds both inside and outside the company.\nApple's promise last month to check U.S. customer phones and computers for child sex abuse images sparked a global backlash from a wide range of rights groups, with employees also criticizing the plan internally.\nCritics argued the feature could be exploited by repressive governments looking to find other material for censorship or arrests and would also be impossible for outside researchers to determine whether Apple was only checking a small set of on-device content.\nApple countered that it would allow security researchers to verify its claims, but the company on Friday said it would take more time to make changes to the system.\n\"Based on feedback from customers, advocacy groups, researchers and others, we have decided to take additional time over the coming months to collect input and make improvements before releasing these critically important child safety features,\" the company said in a statement on Friday.\nMatthew Green, a cybersecurity researcher at Johns Hopkins University who had criticized Apple's move, said the Apple's move was \"promising.\"\nGreen said on Twitter that Apple should \"be clear about why you’re scanning and what you’re scanning. Going from scanning nothing (but email attachments) to scanning everyone’s private photo library was an enormous delta. You need to justify escalations like this.\"\nApple had been playing defense on the plan for weeks, and had already offered a series of explanations and documents to show that the risks of false detections were low.\nIt had planned to roll out the feature for iPhones, iPads, and Mac with software updates later this year in the United States.","news_type":1},"isVote":1,"tweetType":1,"viewCount":579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838990769,"gmtCreate":1629362601251,"gmtModify":1676530015796,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"I doubt it. J&amp;J vaccine safety record makes it far more wary to the public&nbsp;","listText":"I doubt it. J&amp;J vaccine safety record makes it far more wary to the public&nbsp;","text":"I doubt it. J&J vaccine safety record makes it far more wary to the public","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838990769","repostId":"2160322137","repostType":4,"repost":{"id":"2160322137","kind":"highlight","pubTimestamp":1629361286,"share":"https://ttm.financial/m/news/2160322137?lang=&edition=fundamental","pubTime":"2021-08-19 16:21","market":"us","language":"en","title":"Here's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2160322137","media":"Motley Fool","summary":"A new South African study shows the one-dose vaccine is highly effective against the delta variant.","content":"<p><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a> 's (NYSE:JNJ) COVID-19 vaccine has had some challenges this year. From production issues to some disquieting reports of blood clots possibly being linked to the vaccine, it hasn't been the success the company was likely hoping it would be at this stage.&nbsp;Vaccines from <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (NYSE:PFE) and <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (NASDAQ:MRNA) have generated far more revenue for those companies and appear to be the vaccines of choice for many people.</p>\n<p>However, the delta variant may change that, as both Moderna and Pfizer are suggesting booster shots are necessary. And the Food and Drug Administration (FDA) recently authorized a third dose for people with weakened immune systems. Meanwhile, a new study has found the Johnson &amp; Johnson vaccine to be highly effective against the delta variant, so booster shots may not be necessary for individuals who receive that vaccine. While a lack of boosters won't translate to more revenue from the vaccine, it's a development that could ultimately lead to Johnson &amp; Johnson's vaccine rising in popularity and grabbing more market share.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F639287%2Fa-person-receiving-a-vaccine-from-a-nurse.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>The underdog vaccine?</h2>\n<p>Johnson &amp; Johnson expects to make $2.5 billion in revenue from its COVID-19 vaccine in 2021. That's a drop in the bucket for the mammoth business, which generated more than $80 billion in revenue in 2020.</p>\n<p>Moderna's vaccine sales could reach $20 billion by the end of this year. And that's still well behind Pfizer, which estimates its vaccine sales will hit $33.5 billion this year as it leads the way, producing up to 3 billion doses in 2021. Moderna doesn't anticipate it will be able to produce that many doses annually until next year. In 2021, its production could reach 1 billion doses.</p>\n<p>Johnson &amp; Johnson only expects to produce up to 600 million doses of its single-shot vaccine this year, down from its earlier target of 1 billion. Its struggles stem in large part from difficulties at a plant in Baltimore run by <b>Emergent BioSolutions</b>, where concerns relating to cross-contamination led to a shutdown of its factory in March. The FDA only recently gave the plant the green light to reopen.</p>\n<p>It also didn't help that some people felt, correctly or not, that J&amp;J's vaccine wasn't as effective as the other ones granted Emergency Use Authorization by the FDA.</p>\n<h2>J&amp;J's efficacy numbers don't tell the whole story</h2>\n<p>One of the challenges that Johnson &amp; Johnson's vaccine has faced is that from the start, it didn't look like it stacked up well against the shots from Moderna and Pfizer. In January, the company reported that its vaccine was 66% effective in preventing moderate and severe cases of COVID-19. In preventing severe disease only, that figure rose to 85%. However, that looks far less impressive than the vaccines from Pfizer and Moderna, both of which demonstrated more than 90% efficacy when those companies reported the results of their trials in November 2020.</p>\n<p>But the problem is that Johnson &amp; Johnson's vaccine data were never a fair comparison: It only completed <i>enrolling</i> participants in the first phase of its vaccine trial a month later, in December 2020. By then, coronavirus had evolved and new variants of concern were emerging in the U.K., Brazil, and South Africa. In Moderna's and Pfizer's earlier trials, those variants would not have played as much of a role (if at all) in their overall efficacy rates as they did in Johnson &amp; Johnson's trials; when looking at just the U.S., J&amp;J's vaccine efficacy rose to 72% in preventing moderate and severe disease.</p>\n<p>From the start, J&amp;J's vaccine was disadvantaged because of the numbers, which inevitably led to comparisons. But there's a new study that could be much more promising for Johnson &amp; Johnson and lead to greater demand for its shot.</p>\n<h2>High effectiveness against the delta variant</h2>\n<p>A new study from South Africa, called Sisonke, has shown Johnson &amp; Johnson's vaccine to be highly effective against <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most concerning variants around right now -- delta. The trial is massive and involves 480,000 healthcare workers (Johnson &amp; Johnson's initial phase 3 trial was relatively large and had only 45,000 participants). Although the data hasn't been peer-reviewed, the initial numbers are extremely encouraging -- showing 71% efficacy in preventing hospitalizations in delta-related cases. And in terms of preventing death, the overall efficacy rose to 96%.</p>\n<p>By comparison, studies on two doses of the Pfizer vaccine suggest efficacy rates could range between 42% and 96% against delta. Moderna has also had varying efficacy rates but it looks to be a bit higher, at around 76%. But what's common to both is that people need two doses of the vaccine, as a single dose offers weaker protection. And that's where the advantage could sway significantly in Johnson &amp; Johnson's favor as its single-shot vaccine would be significantly easier to administer.</p>\n<h2>Is this a game-changer for Johnson &amp; Johnson?</h2>\n<p>Johnson &amp; Johnson's vaccine could quickly help countries around the world increase their vaccination rates. Without having to wait several weeks between doses, a single-shot vaccine that's effective against the delta variant could be in high demand.</p>\n<p>If production-related issues are sorted out and concerns ease about its efficacy, Johnson &amp; Johnson could make up some serious ground in the COVID-19 vaccine market. It has a long way to go in overtaking Pfizer and Moderna in market share, but the healthcare giant is a major player in the industry with significant resources. It could ramp up production to meet a surge in demand. And that's why investors shouldn't count out the role that vaccine sales may play in its future.</p>\n<p>But there is danger in investing based on a specific COVID-19 variant. Things have been changing rapidly, and a new variant could emerge that renders all of the currently available vaccines nearly useless. And so while Johnson &amp; Johnson's vaccine does look like it should rebound in the future, and even though it has an outside chance of overtaking both Moderna and Pfizer, those factors aren't enough to make it a sure thing; there's just too much uncertainty. The stock isn't all that safe over the long term either; Johnson &amp; Johnson's legal troubles in other areas of its business are enough of a reason for me to stay away from the stock.</p>\n<p>However, if you are comfortable with the risk and uncertainty and want exposure to the COVID-19 vaccine market, investing in Johnson &amp; Johnson is still a better option than buying shares of a soaring stock like Moderna, which is trading more than $100 higher than price targets set by even some of the most bullish of analysts. And given that it is a bit of an underdog in this race, Johnson &amp; Johnson's ability to produce some better-than-anticipated vaccine sales could lead to significant analyst upgrades, which, in turn, may lead to some great returns for shareholders who buy the stock today.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 16:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/18/heres-why-johnson-johnsons-vaccine-could-overtake/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Johnson & Johnson 's (NYSE:JNJ) COVID-19 vaccine has had some challenges this year. From production issues to some disquieting reports of blood clots possibly being linked to the vaccine, it hasn't ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/18/heres-why-johnson-johnsons-vaccine-could-overtake/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/08/18/heres-why-johnson-johnsons-vaccine-could-overtake/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160322137","content_text":"Johnson & Johnson 's (NYSE:JNJ) COVID-19 vaccine has had some challenges this year. From production issues to some disquieting reports of blood clots possibly being linked to the vaccine, it hasn't been the success the company was likely hoping it would be at this stage. Vaccines from Pfizer (NYSE:PFE) and Moderna, Inc. (NASDAQ:MRNA) have generated far more revenue for those companies and appear to be the vaccines of choice for many people.\nHowever, the delta variant may change that, as both Moderna and Pfizer are suggesting booster shots are necessary. And the Food and Drug Administration (FDA) recently authorized a third dose for people with weakened immune systems. Meanwhile, a new study has found the Johnson & Johnson vaccine to be highly effective against the delta variant, so booster shots may not be necessary for individuals who receive that vaccine. While a lack of boosters won't translate to more revenue from the vaccine, it's a development that could ultimately lead to Johnson & Johnson's vaccine rising in popularity and grabbing more market share.\n\nImage source: Getty Images.\nThe underdog vaccine?\nJohnson & Johnson expects to make $2.5 billion in revenue from its COVID-19 vaccine in 2021. That's a drop in the bucket for the mammoth business, which generated more than $80 billion in revenue in 2020.\nModerna's vaccine sales could reach $20 billion by the end of this year. And that's still well behind Pfizer, which estimates its vaccine sales will hit $33.5 billion this year as it leads the way, producing up to 3 billion doses in 2021. Moderna doesn't anticipate it will be able to produce that many doses annually until next year. In 2021, its production could reach 1 billion doses.\nJohnson & Johnson only expects to produce up to 600 million doses of its single-shot vaccine this year, down from its earlier target of 1 billion. Its struggles stem in large part from difficulties at a plant in Baltimore run by Emergent BioSolutions, where concerns relating to cross-contamination led to a shutdown of its factory in March. The FDA only recently gave the plant the green light to reopen.\nIt also didn't help that some people felt, correctly or not, that J&J's vaccine wasn't as effective as the other ones granted Emergency Use Authorization by the FDA.\nJ&J's efficacy numbers don't tell the whole story\nOne of the challenges that Johnson & Johnson's vaccine has faced is that from the start, it didn't look like it stacked up well against the shots from Moderna and Pfizer. In January, the company reported that its vaccine was 66% effective in preventing moderate and severe cases of COVID-19. In preventing severe disease only, that figure rose to 85%. However, that looks far less impressive than the vaccines from Pfizer and Moderna, both of which demonstrated more than 90% efficacy when those companies reported the results of their trials in November 2020.\nBut the problem is that Johnson & Johnson's vaccine data were never a fair comparison: It only completed enrolling participants in the first phase of its vaccine trial a month later, in December 2020. By then, coronavirus had evolved and new variants of concern were emerging in the U.K., Brazil, and South Africa. In Moderna's and Pfizer's earlier trials, those variants would not have played as much of a role (if at all) in their overall efficacy rates as they did in Johnson & Johnson's trials; when looking at just the U.S., J&J's vaccine efficacy rose to 72% in preventing moderate and severe disease.\nFrom the start, J&J's vaccine was disadvantaged because of the numbers, which inevitably led to comparisons. But there's a new study that could be much more promising for Johnson & Johnson and lead to greater demand for its shot.\nHigh effectiveness against the delta variant\nA new study from South Africa, called Sisonke, has shown Johnson & Johnson's vaccine to be highly effective against one of the most concerning variants around right now -- delta. The trial is massive and involves 480,000 healthcare workers (Johnson & Johnson's initial phase 3 trial was relatively large and had only 45,000 participants). Although the data hasn't been peer-reviewed, the initial numbers are extremely encouraging -- showing 71% efficacy in preventing hospitalizations in delta-related cases. And in terms of preventing death, the overall efficacy rose to 96%.\nBy comparison, studies on two doses of the Pfizer vaccine suggest efficacy rates could range between 42% and 96% against delta. Moderna has also had varying efficacy rates but it looks to be a bit higher, at around 76%. But what's common to both is that people need two doses of the vaccine, as a single dose offers weaker protection. And that's where the advantage could sway significantly in Johnson & Johnson's favor as its single-shot vaccine would be significantly easier to administer.\nIs this a game-changer for Johnson & Johnson?\nJohnson & Johnson's vaccine could quickly help countries around the world increase their vaccination rates. Without having to wait several weeks between doses, a single-shot vaccine that's effective against the delta variant could be in high demand.\nIf production-related issues are sorted out and concerns ease about its efficacy, Johnson & Johnson could make up some serious ground in the COVID-19 vaccine market. It has a long way to go in overtaking Pfizer and Moderna in market share, but the healthcare giant is a major player in the industry with significant resources. It could ramp up production to meet a surge in demand. And that's why investors shouldn't count out the role that vaccine sales may play in its future.\nBut there is danger in investing based on a specific COVID-19 variant. Things have been changing rapidly, and a new variant could emerge that renders all of the currently available vaccines nearly useless. And so while Johnson & Johnson's vaccine does look like it should rebound in the future, and even though it has an outside chance of overtaking both Moderna and Pfizer, those factors aren't enough to make it a sure thing; there's just too much uncertainty. The stock isn't all that safe over the long term either; Johnson & Johnson's legal troubles in other areas of its business are enough of a reason for me to stay away from the stock.\nHowever, if you are comfortable with the risk and uncertainty and want exposure to the COVID-19 vaccine market, investing in Johnson & Johnson is still a better option than buying shares of a soaring stock like Moderna, which is trading more than $100 higher than price targets set by even some of the most bullish of analysts. And given that it is a bit of an underdog in this race, Johnson & Johnson's ability to produce some better-than-anticipated vaccine sales could lead to significant analyst upgrades, which, in turn, may lead to some great returns for shareholders who buy the stock today.","news_type":1},"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838990921,"gmtCreate":1629362524263,"gmtModify":1676530015776,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/838990921","repostId":"1199508807","repostType":4,"isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9095130167,"gmtCreate":1644848444599,"gmtModify":1676533967448,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"No matter what we will still have to be ready for the crash","listText":"No matter what we will still have to be ready for the crash","text":"No matter what we will still have to be ready for the crash","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9095130167","repostId":"2211652081","repostType":4,"repost":{"id":"2211652081","kind":"highlight","pubTimestamp":1644847200,"share":"https://ttm.financial/m/news/2211652081?lang=&edition=fundamental","pubTime":"2022-02-14 22:00","market":"us","language":"en","title":"4 Reasons Not to Worry About a Stock Market Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2211652081","media":"Motley Fool","summary":"Market crashes happen. You can't prevent them, but you can put yourself in a position to emerge stronger once they pass.","content":"<html><head></head><body><p>The stock market will crash again. It&#39;s not a question of whether, but rather when. Perhaps the biggest near-term risk is that high and still rising inflation might provide the push that causes the next major drop. How? Well, the Federal Reserve&#39;s expedited meeting scheduled for Monday might lead to faster and more aggressive tapering than the market already expects. That could cause a shift out of riskier assets like stocks, leading to a market correction.</p><p>Whether or not that particular scenario comes into play, the reality is that stocks can go down as well as up. If you recognize that and plan for it appropriately, you can make it through a mere market crash -- and emerge on the other side in a great spot to ride any subsequent recovery.</p><p>With that in mind, here are four reasons not to worry about a stock-market crash.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1237784dd4415f4c114f5922023f8e01\" tg-width=\"700\" tg-height=\"312\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>1. You don&#39;t need to sell your stocks today</h2><p>As a general rule, you should not have money invested in stocks that you expect you&#39;ll need to spend within the next five years. If you have followed that guideline, it becomes much easier to stomach a market crash. It&#39;s still not fun, but you can make it through.</p><p>After all, if you don&#39;t need the money immediately, then you don&#39;t have to sell shares when they&#39;re low just to cover your bills. That gives you the chance to not only hold on through a crash, but also to potentially add more to strong companies while they&#39;re near their cheapest. The ability to buy low -- instead of selling low -- allows you to end up in a better spot once the crash passes.</p><h2>2. You have emergency money stocked away, just in case</h2><p>One of the bigger risks most people face when the market crashes isn&#39;t the crash itself, but rather the fact that a down market is often linked to job losses. Even if you fully intend to hold on to your stocks through a crash, if you find yourself without a paycheck and with no cash buffer, you could wind up needing to sell due to that job loss.</p><p>A three- to six-month emergency fund buys you time to both look for another job and figure out ways to cut costs before you feel forced to sell your shares. It&#39;s a buffer that can come in incredibly handy in a tough environment. It&#39;s also <a href=\"https://laohu8.com/S/AONE.U\">one</a> of those things that you hope you&#39;ll never have to use -- but if you do, you&#39;ll be incredibly glad it&#39;s there when you need it.</p><h2>3. You own strong companies that still pay their dividends</h2><p>The beauty of a stock&#39;s dividend is that it tends to get paid based on the underlying company&#39;s ability to generate cash, rather than on the stock market&#39;s short-term mood. When companies continue to pay their dividends in a down market, that helps investors in a number of ways.</p><p>First, the cash itself can be used to buy more shares while they&#39;re down -- either of the company that paid the dividend, or of a different one that looks like a compelling value at a low price. That cash becomes available without you having to sell stock or somehow scaring up money from another source, which can be comforting if you&#39;re a bit nervous about the future.</p><p>Second, the fact that companies continue to make their payments from available cash flows can provide a calming effect for investors, even as the market appears to panic around them. After all, there&#39;s nothing quite like cold, hard cash to remind people that there&#39;s a business behind each stock. If a dividend is still supported and getting paid, it means there&#39;s still a successful company there, no matter what the stock price might say at the moment.</p><h2>4. You have a value investor&#39;s mindset</h2><p>Ultimately, a share of stock is an ownership stake in a business. If that business is currently profitable and expected to remain that way, each share is certainly worth <i>something</i>. Value investors recognize that a company&#39;s intrinsic worth is based on its ability to generate cash over time, and not simply on what the market thinks its shares should be priced at today.</p><p>As a result, a market crash can make great companies&#39; shares available at a price below what those value investors believe they&#39;re really worth. That sort of pricing turns value investors into aggressive buyers during a crash, and it&#39;s a key part of the strategy that helped Warren Buffett earn and expand his fortune.</p><p>Especially when combined with the first three reasons not to worry about a stock-market crash, this fourth reason can actually give you an opportunity to profit from one. After all, if you&#39;ve got the cash to ride out the decline <i>and</i> the wherewithal to buy near the lows, you have the opportunity to make some serious coin in any subsequent recovery.</p><h2>Are you ready for the next crash?</h2><p>While these four factors can help you make it through a market crash with much less worry, they all work much better if you have them in place before you need them. So start getting your plan in place today. That way, you&#39;ll be in a much better place the next time the market crashes.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Reasons Not to Worry About a Stock Market Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Reasons Not to Worry About a Stock Market Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-14 22:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/02/13/4-reasons-not-to-worry-about-a-stock-market-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market will crash again. It's not a question of whether, but rather when. Perhaps the biggest near-term risk is that high and still rising inflation might provide the push that causes the ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/13/4-reasons-not-to-worry-about-a-stock-market-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.fool.com/investing/2022/02/13/4-reasons-not-to-worry-about-a-stock-market-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2211652081","content_text":"The stock market will crash again. It's not a question of whether, but rather when. Perhaps the biggest near-term risk is that high and still rising inflation might provide the push that causes the next major drop. How? Well, the Federal Reserve's expedited meeting scheduled for Monday might lead to faster and more aggressive tapering than the market already expects. That could cause a shift out of riskier assets like stocks, leading to a market correction.Whether or not that particular scenario comes into play, the reality is that stocks can go down as well as up. If you recognize that and plan for it appropriately, you can make it through a mere market crash -- and emerge on the other side in a great spot to ride any subsequent recovery.With that in mind, here are four reasons not to worry about a stock-market crash.Image source: Getty Images.1. You don't need to sell your stocks todayAs a general rule, you should not have money invested in stocks that you expect you'll need to spend within the next five years. If you have followed that guideline, it becomes much easier to stomach a market crash. It's still not fun, but you can make it through.After all, if you don't need the money immediately, then you don't have to sell shares when they're low just to cover your bills. That gives you the chance to not only hold on through a crash, but also to potentially add more to strong companies while they're near their cheapest. The ability to buy low -- instead of selling low -- allows you to end up in a better spot once the crash passes.2. You have emergency money stocked away, just in caseOne of the bigger risks most people face when the market crashes isn't the crash itself, but rather the fact that a down market is often linked to job losses. Even if you fully intend to hold on to your stocks through a crash, if you find yourself without a paycheck and with no cash buffer, you could wind up needing to sell due to that job loss.A three- to six-month emergency fund buys you time to both look for another job and figure out ways to cut costs before you feel forced to sell your shares. It's a buffer that can come in incredibly handy in a tough environment. It's also one of those things that you hope you'll never have to use -- but if you do, you'll be incredibly glad it's there when you need it.3. You own strong companies that still pay their dividendsThe beauty of a stock's dividend is that it tends to get paid based on the underlying company's ability to generate cash, rather than on the stock market's short-term mood. When companies continue to pay their dividends in a down market, that helps investors in a number of ways.First, the cash itself can be used to buy more shares while they're down -- either of the company that paid the dividend, or of a different one that looks like a compelling value at a low price. That cash becomes available without you having to sell stock or somehow scaring up money from another source, which can be comforting if you're a bit nervous about the future.Second, the fact that companies continue to make their payments from available cash flows can provide a calming effect for investors, even as the market appears to panic around them. After all, there's nothing quite like cold, hard cash to remind people that there's a business behind each stock. If a dividend is still supported and getting paid, it means there's still a successful company there, no matter what the stock price might say at the moment.4. You have a value investor's mindsetUltimately, a share of stock is an ownership stake in a business. If that business is currently profitable and expected to remain that way, each share is certainly worth something. Value investors recognize that a company's intrinsic worth is based on its ability to generate cash over time, and not simply on what the market thinks its shares should be priced at today.As a result, a market crash can make great companies' shares available at a price below what those value investors believe they're really worth. That sort of pricing turns value investors into aggressive buyers during a crash, and it's a key part of the strategy that helped Warren Buffett earn and expand his fortune.Especially when combined with the first three reasons not to worry about a stock-market crash, this fourth reason can actually give you an opportunity to profit from one. After all, if you've got the cash to ride out the decline and the wherewithal to buy near the lows, you have the opportunity to make some serious coin in any subsequent recovery.Are you ready for the next crash?While these four factors can help you make it through a market crash with much less worry, they all work much better if you have them in place before you need them. So start getting your plan in place today. That way, you'll be in a much better place the next time the market crashes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":370,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"content":"market correction is inevitable","text":"market correction is inevitable","html":"market correction is inevitable"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9091513403,"gmtCreate":1643898349602,"gmtModify":1676533868988,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"This is the future","listText":"This is the future","text":"This is the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9091513403","repostId":"1196144953","repostType":4,"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814311016,"gmtCreate":1630762091735,"gmtModify":1676530391497,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/814311016","repostId":"1107645720","repostType":4,"isVote":1,"tweetType":1,"viewCount":579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838990921,"gmtCreate":1629362524263,"gmtModify":1676530015776,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/838990921","repostId":"1199508807","repostType":4,"isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9030529014,"gmtCreate":1645758376921,"gmtModify":1676534061845,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"😮","listText":"😮","text":"😮","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030529014","repostId":"1145816604","repostType":4,"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001698011,"gmtCreate":1641228150205,"gmtModify":1676533585638,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Tesla showing strength once again","listText":"Tesla showing strength once again","text":"Tesla showing strength once again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001698011","repostId":"2200544080","repostType":2,"repost":{"id":"2200544080","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641163106,"share":"https://ttm.financial/m/news/2200544080?lang=&edition=fundamental","pubTime":"2022-01-03 06:38","market":"us","language":"en","title":"Tesla delivers 308,600 vehicles in Q4, beating estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2200544080","media":"Reuters","summary":"Jan 2  - Tesla Incon Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and ","content":"<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla delivers 308,600 vehicles in Q4, beating estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla delivers 308,600 vehicles in Q4, beating estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-03 06:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4099":"汽车制造商","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4555":"新能源车","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200544080","content_text":"Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.\"Great work by Tesla team worldwide!\" Musk wrote on Twitter.His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.Tesla ships China-made models to Europe and some Asian countries.On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for \"quite a while.\"NEW FACTORIES\"They have beaten all the odds,\" Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.\"The first is the demand for their products is through the roof. And the second is they're doing a great job of meeting that demand,\" he said.Munster said he expected Tesla's deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.'SUPER CRAZY' SHORTAGESIn 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.Musk, who previously said, \"2021 has been the year of super crazy supply chain shortages,\" said in October that he was optimistic that those issues would pass in 2022.The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company's shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.Overall, Tesla shares gained 50% last year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007951064,"gmtCreate":1642748141098,"gmtModify":1676533742677,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007951064","repostId":"1149128826","repostType":4,"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001698313,"gmtCreate":1641228211260,"gmtModify":1676533585630,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001698313","repostId":"2200544080","repostType":2,"repost":{"id":"2200544080","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641163106,"share":"https://ttm.financial/m/news/2200544080?lang=&edition=fundamental","pubTime":"2022-01-03 06:38","market":"us","language":"en","title":"Tesla delivers 308,600 vehicles in Q4, beating estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2200544080","media":"Reuters","summary":"Jan 2  - Tesla Incon Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and ","content":"<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla delivers 308,600 vehicles in Q4, beating estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla delivers 308,600 vehicles in Q4, beating estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-03 06:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.</p><p>It was the sixth consecutive quarter that the world&#39;s most valuable automaker posted record deliveries.</p><p>Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts&#39; forecasts of 263,026 vehicles.</p><p>Tesla&#39;s October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.</p><p>&#34;Great work by Tesla team worldwide!&#34; Musk wrote on Twitter.</p><p>His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.</p><p>Tesla ships China-made models to Europe and some Asian countries.</p><p>On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.</p><p>Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for &#34;quite a while.&#34;</p><p><b>NEW FACTORIES</b></p><p>&#34;They have beaten all the odds,&#34; Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.</p><p>&#34;The first is the demand for their products is through the roof. And the second is they&#39;re doing a great job of meeting that demand,&#34; he said.</p><p>Munster said he expected Tesla&#39;s deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.</p><p>Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.</p><p>Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.</p><p>Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.</p><p><b>&#39;SUPER CRAZY&#39; SHORTAGES</b></p><p>In 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.</p><p>Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.</p><p>Musk, who previously said, &#34;2021 has been the year of super crazy supply chain shortages,&#34; said in October that he was optimistic that those issues would pass in 2022.</p><p>The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.</p><p>Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company&#39;s shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.</p><p>Overall, Tesla shares gained 50% last year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4099":"汽车制造商","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4555":"新能源车","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200544080","content_text":"Jan 2 (Reuters) - Tesla Inc on Sunday reported record quarterly deliveries that far exceeded Wall Street estimates, riding out global chip shortages as it ramped up China production.It was the sixth consecutive quarter that the world's most valuable automaker posted record deliveries.Tesla, led by billionaire CEO Elon Musk, delivered 308,600 vehicles in the fourth quarter, far higher than analysts' forecasts of 263,026 vehicles.Tesla's October-December deliveries were up about 70% from a year earlier and nearly 30% higher from record deliveries the preceding quarter.\"Great work by Tesla team worldwide!\" Musk wrote on Twitter.His electric car company ramped up production in China even though competition rose and regulatory pressure mounted following consumer complaints over product safety.Tesla ships China-made models to Europe and some Asian countries.On an annual basis, the automaker boosted its deliveries by 87% from a year earlier to 936,172 vehicles in 2021.Musk said in October last year that Tesla will be able to maintain an annual growth rate of more than 50% for \"quite a while.\"NEW FACTORIES\"They have beaten all the odds,\" Gene Munster, managing partner at venture capital firm Loup Ventures, said on Sunday.\"The first is the demand for their products is through the roof. And the second is they're doing a great job of meeting that demand,\" he said.Munster said he expected Tesla's deliveries to grow to 1.3 million vehicles this year despite headwinds in production at its new factories and supply chain problems.Tesla Chief Financial Officer Zachary Kirkhorn said in October that it was difficult to predict how quickly the company will be able to boost production at new factories in Texas and Berlin, which will use new vehicle technologies and new teams.Tesla said in October that it aimed to build its first production cars at both facilities by the end of 2021, but it is not known whether it met that target. Tesla did not respond to a question from Reuters about the plants. Its Berlin factory had initially been scheduled to begin production last summer.Deutsche Bank said in a report on Friday that it expected Tesla to make nearly 1.5 million vehicle deliveries this year, although chip shortages remain a risk to production.'SUPER CRAZY' SHORTAGESIn 2020, automakers cut chip orders as the pandemic and lockdown measures hit demand. But Tesla never reduced its production forecast with suppliers to support its rapid growth plan, which helped it weather the chip shortage, Musk has said.Tesla, which designs some chips in-house unlike most automakers, also reprogrammed software to use less scarce chips, according to Musk.Musk, who previously said, \"2021 has been the year of super crazy supply chain shortages,\" said in October that he was optimistic that those issues would pass in 2022.The strong sales came even after Tesla hiked U.S. vehicle prices sharply this year to offset higher supply chain costs.Tesla hit over $1 trillion in market capitalization in October after rental car company Hertz said it ordered 100,000 of its vehicles. The company's shares lost some ground after Musk wrote on Twitter in November that he was considering selling 10% of his stake in Tesla.Overall, Tesla shares gained 50% last year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838990769,"gmtCreate":1629362601251,"gmtModify":1676530015796,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"I doubt it. J&amp;J vaccine safety record makes it far more wary to the public&nbsp;","listText":"I doubt it. J&amp;J vaccine safety record makes it far more wary to the public&nbsp;","text":"I doubt it. J&J vaccine safety record makes it far more wary to the public","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838990769","repostId":"2160322137","repostType":4,"repost":{"id":"2160322137","kind":"highlight","pubTimestamp":1629361286,"share":"https://ttm.financial/m/news/2160322137?lang=&edition=fundamental","pubTime":"2021-08-19 16:21","market":"us","language":"en","title":"Here's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2160322137","media":"Motley Fool","summary":"A new South African study shows the one-dose vaccine is highly effective against the delta variant.","content":"<p><a href=\"https://laohu8.com/S/JNJ\">Johnson &amp; Johnson</a> 's (NYSE:JNJ) COVID-19 vaccine has had some challenges this year. From production issues to some disquieting reports of blood clots possibly being linked to the vaccine, it hasn't been the success the company was likely hoping it would be at this stage.&nbsp;Vaccines from <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (NYSE:PFE) and <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (NASDAQ:MRNA) have generated far more revenue for those companies and appear to be the vaccines of choice for many people.</p>\n<p>However, the delta variant may change that, as both Moderna and Pfizer are suggesting booster shots are necessary. And the Food and Drug Administration (FDA) recently authorized a third dose for people with weakened immune systems. Meanwhile, a new study has found the Johnson &amp; Johnson vaccine to be highly effective against the delta variant, so booster shots may not be necessary for individuals who receive that vaccine. While a lack of boosters won't translate to more revenue from the vaccine, it's a development that could ultimately lead to Johnson &amp; Johnson's vaccine rising in popularity and grabbing more market share.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F639287%2Fa-person-receiving-a-vaccine-from-a-nurse.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>The underdog vaccine?</h2>\n<p>Johnson &amp; Johnson expects to make $2.5 billion in revenue from its COVID-19 vaccine in 2021. That's a drop in the bucket for the mammoth business, which generated more than $80 billion in revenue in 2020.</p>\n<p>Moderna's vaccine sales could reach $20 billion by the end of this year. And that's still well behind Pfizer, which estimates its vaccine sales will hit $33.5 billion this year as it leads the way, producing up to 3 billion doses in 2021. Moderna doesn't anticipate it will be able to produce that many doses annually until next year. In 2021, its production could reach 1 billion doses.</p>\n<p>Johnson &amp; Johnson only expects to produce up to 600 million doses of its single-shot vaccine this year, down from its earlier target of 1 billion. Its struggles stem in large part from difficulties at a plant in Baltimore run by <b>Emergent BioSolutions</b>, where concerns relating to cross-contamination led to a shutdown of its factory in March. The FDA only recently gave the plant the green light to reopen.</p>\n<p>It also didn't help that some people felt, correctly or not, that J&amp;J's vaccine wasn't as effective as the other ones granted Emergency Use Authorization by the FDA.</p>\n<h2>J&amp;J's efficacy numbers don't tell the whole story</h2>\n<p>One of the challenges that Johnson &amp; Johnson's vaccine has faced is that from the start, it didn't look like it stacked up well against the shots from Moderna and Pfizer. In January, the company reported that its vaccine was 66% effective in preventing moderate and severe cases of COVID-19. In preventing severe disease only, that figure rose to 85%. However, that looks far less impressive than the vaccines from Pfizer and Moderna, both of which demonstrated more than 90% efficacy when those companies reported the results of their trials in November 2020.</p>\n<p>But the problem is that Johnson &amp; Johnson's vaccine data were never a fair comparison: It only completed <i>enrolling</i> participants in the first phase of its vaccine trial a month later, in December 2020. By then, coronavirus had evolved and new variants of concern were emerging in the U.K., Brazil, and South Africa. In Moderna's and Pfizer's earlier trials, those variants would not have played as much of a role (if at all) in their overall efficacy rates as they did in Johnson &amp; Johnson's trials; when looking at just the U.S., J&amp;J's vaccine efficacy rose to 72% in preventing moderate and severe disease.</p>\n<p>From the start, J&amp;J's vaccine was disadvantaged because of the numbers, which inevitably led to comparisons. But there's a new study that could be much more promising for Johnson &amp; Johnson and lead to greater demand for its shot.</p>\n<h2>High effectiveness against the delta variant</h2>\n<p>A new study from South Africa, called Sisonke, has shown Johnson &amp; Johnson's vaccine to be highly effective against <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most concerning variants around right now -- delta. The trial is massive and involves 480,000 healthcare workers (Johnson &amp; Johnson's initial phase 3 trial was relatively large and had only 45,000 participants). Although the data hasn't been peer-reviewed, the initial numbers are extremely encouraging -- showing 71% efficacy in preventing hospitalizations in delta-related cases. And in terms of preventing death, the overall efficacy rose to 96%.</p>\n<p>By comparison, studies on two doses of the Pfizer vaccine suggest efficacy rates could range between 42% and 96% against delta. Moderna has also had varying efficacy rates but it looks to be a bit higher, at around 76%. But what's common to both is that people need two doses of the vaccine, as a single dose offers weaker protection. And that's where the advantage could sway significantly in Johnson &amp; Johnson's favor as its single-shot vaccine would be significantly easier to administer.</p>\n<h2>Is this a game-changer for Johnson &amp; Johnson?</h2>\n<p>Johnson &amp; Johnson's vaccine could quickly help countries around the world increase their vaccination rates. Without having to wait several weeks between doses, a single-shot vaccine that's effective against the delta variant could be in high demand.</p>\n<p>If production-related issues are sorted out and concerns ease about its efficacy, Johnson &amp; Johnson could make up some serious ground in the COVID-19 vaccine market. It has a long way to go in overtaking Pfizer and Moderna in market share, but the healthcare giant is a major player in the industry with significant resources. It could ramp up production to meet a surge in demand. And that's why investors shouldn't count out the role that vaccine sales may play in its future.</p>\n<p>But there is danger in investing based on a specific COVID-19 variant. Things have been changing rapidly, and a new variant could emerge that renders all of the currently available vaccines nearly useless. And so while Johnson &amp; Johnson's vaccine does look like it should rebound in the future, and even though it has an outside chance of overtaking both Moderna and Pfizer, those factors aren't enough to make it a sure thing; there's just too much uncertainty. The stock isn't all that safe over the long term either; Johnson &amp; Johnson's legal troubles in other areas of its business are enough of a reason for me to stay away from the stock.</p>\n<p>However, if you are comfortable with the risk and uncertainty and want exposure to the COVID-19 vaccine market, investing in Johnson &amp; Johnson is still a better option than buying shares of a soaring stock like Moderna, which is trading more than $100 higher than price targets set by even some of the most bullish of analysts. And given that it is a bit of an underdog in this race, Johnson &amp; Johnson's ability to produce some better-than-anticipated vaccine sales could lead to significant analyst upgrades, which, in turn, may lead to some great returns for shareholders who buy the stock today.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Johnson & Johnson's Vaccine Could Overtake Both Pfizer and Moderna\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 16:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/18/heres-why-johnson-johnsons-vaccine-could-overtake/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Johnson & Johnson 's (NYSE:JNJ) COVID-19 vaccine has had some challenges this year. From production issues to some disquieting reports of blood clots possibly being linked to the vaccine, it hasn't ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/18/heres-why-johnson-johnsons-vaccine-could-overtake/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc.","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/08/18/heres-why-johnson-johnsons-vaccine-could-overtake/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160322137","content_text":"Johnson & Johnson 's (NYSE:JNJ) COVID-19 vaccine has had some challenges this year. From production issues to some disquieting reports of blood clots possibly being linked to the vaccine, it hasn't been the success the company was likely hoping it would be at this stage. Vaccines from Pfizer (NYSE:PFE) and Moderna, Inc. (NASDAQ:MRNA) have generated far more revenue for those companies and appear to be the vaccines of choice for many people.\nHowever, the delta variant may change that, as both Moderna and Pfizer are suggesting booster shots are necessary. And the Food and Drug Administration (FDA) recently authorized a third dose for people with weakened immune systems. Meanwhile, a new study has found the Johnson & Johnson vaccine to be highly effective against the delta variant, so booster shots may not be necessary for individuals who receive that vaccine. While a lack of boosters won't translate to more revenue from the vaccine, it's a development that could ultimately lead to Johnson & Johnson's vaccine rising in popularity and grabbing more market share.\n\nImage source: Getty Images.\nThe underdog vaccine?\nJohnson & Johnson expects to make $2.5 billion in revenue from its COVID-19 vaccine in 2021. That's a drop in the bucket for the mammoth business, which generated more than $80 billion in revenue in 2020.\nModerna's vaccine sales could reach $20 billion by the end of this year. And that's still well behind Pfizer, which estimates its vaccine sales will hit $33.5 billion this year as it leads the way, producing up to 3 billion doses in 2021. Moderna doesn't anticipate it will be able to produce that many doses annually until next year. In 2021, its production could reach 1 billion doses.\nJohnson & Johnson only expects to produce up to 600 million doses of its single-shot vaccine this year, down from its earlier target of 1 billion. Its struggles stem in large part from difficulties at a plant in Baltimore run by Emergent BioSolutions, where concerns relating to cross-contamination led to a shutdown of its factory in March. The FDA only recently gave the plant the green light to reopen.\nIt also didn't help that some people felt, correctly or not, that J&J's vaccine wasn't as effective as the other ones granted Emergency Use Authorization by the FDA.\nJ&J's efficacy numbers don't tell the whole story\nOne of the challenges that Johnson & Johnson's vaccine has faced is that from the start, it didn't look like it stacked up well against the shots from Moderna and Pfizer. In January, the company reported that its vaccine was 66% effective in preventing moderate and severe cases of COVID-19. In preventing severe disease only, that figure rose to 85%. However, that looks far less impressive than the vaccines from Pfizer and Moderna, both of which demonstrated more than 90% efficacy when those companies reported the results of their trials in November 2020.\nBut the problem is that Johnson & Johnson's vaccine data were never a fair comparison: It only completed enrolling participants in the first phase of its vaccine trial a month later, in December 2020. By then, coronavirus had evolved and new variants of concern were emerging in the U.K., Brazil, and South Africa. In Moderna's and Pfizer's earlier trials, those variants would not have played as much of a role (if at all) in their overall efficacy rates as they did in Johnson & Johnson's trials; when looking at just the U.S., J&J's vaccine efficacy rose to 72% in preventing moderate and severe disease.\nFrom the start, J&J's vaccine was disadvantaged because of the numbers, which inevitably led to comparisons. But there's a new study that could be much more promising for Johnson & Johnson and lead to greater demand for its shot.\nHigh effectiveness against the delta variant\nA new study from South Africa, called Sisonke, has shown Johnson & Johnson's vaccine to be highly effective against one of the most concerning variants around right now -- delta. The trial is massive and involves 480,000 healthcare workers (Johnson & Johnson's initial phase 3 trial was relatively large and had only 45,000 participants). Although the data hasn't been peer-reviewed, the initial numbers are extremely encouraging -- showing 71% efficacy in preventing hospitalizations in delta-related cases. And in terms of preventing death, the overall efficacy rose to 96%.\nBy comparison, studies on two doses of the Pfizer vaccine suggest efficacy rates could range between 42% and 96% against delta. Moderna has also had varying efficacy rates but it looks to be a bit higher, at around 76%. But what's common to both is that people need two doses of the vaccine, as a single dose offers weaker protection. And that's where the advantage could sway significantly in Johnson & Johnson's favor as its single-shot vaccine would be significantly easier to administer.\nIs this a game-changer for Johnson & Johnson?\nJohnson & Johnson's vaccine could quickly help countries around the world increase their vaccination rates. Without having to wait several weeks between doses, a single-shot vaccine that's effective against the delta variant could be in high demand.\nIf production-related issues are sorted out and concerns ease about its efficacy, Johnson & Johnson could make up some serious ground in the COVID-19 vaccine market. It has a long way to go in overtaking Pfizer and Moderna in market share, but the healthcare giant is a major player in the industry with significant resources. It could ramp up production to meet a surge in demand. And that's why investors shouldn't count out the role that vaccine sales may play in its future.\nBut there is danger in investing based on a specific COVID-19 variant. Things have been changing rapidly, and a new variant could emerge that renders all of the currently available vaccines nearly useless. And so while Johnson & Johnson's vaccine does look like it should rebound in the future, and even though it has an outside chance of overtaking both Moderna and Pfizer, those factors aren't enough to make it a sure thing; there's just too much uncertainty. The stock isn't all that safe over the long term either; Johnson & Johnson's legal troubles in other areas of its business are enough of a reason for me to stay away from the stock.\nHowever, if you are comfortable with the risk and uncertainty and want exposure to the COVID-19 vaccine market, investing in Johnson & Johnson is still a better option than buying shares of a soaring stock like Moderna, which is trading more than $100 higher than price targets set by even some of the most bullish of analysts. And given that it is a bit of an underdog in this race, Johnson & Johnson's ability to produce some better-than-anticipated vaccine sales could lead to significant analyst upgrades, which, in turn, may lead to some great returns for shareholders who buy the stock today.","news_type":1},"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007758629,"gmtCreate":1643019750308,"gmtModify":1676533765328,"author":{"id":"4088161478987360","authorId":"4088161478987360","name":"mko2","avatar":"https://static.tigerbbs.com/97227b08b73f92dfa3c97c435e1a0345","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088161478987360","authorIdStr":"4088161478987360"},"themes":[],"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007758629","repostId":"2205020146","repostType":4,"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}